Good News: JHTV Wins Federal Grant to Launch Digital Health Exchange, Thrive Gets New CEO and More

Good News: JHTV Wins Federal Grant to Launch Digital Health Exchange, Thrive Gets New CEO and More
<span>Startup news PGDx looking to raise up to $20 million &ldquo;We are growing, innovating and developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide,&rdquo; the company said in a statement to the Baltimore Business Journal. &ldquo;To support this growth, we are focused on maintaining our strong balance sheet,...</span>

Startup news

    • PGDx looking to raise up to $20 million
      “We are growing, innovating and developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide,” the company said in a statement to the Baltimore Business Journal. “To support this growth, we are focused on maintaining our strong balance sheet, securing efficient access to capital and upholding our financial flexibility.”
    • Protenus raises $17M in Series C funding round
      The Series C round was led by LTP, which focuses on investments in health IT and services companies. The health care cybersecurity firm said the money will help to accelerate sales as it looks to partner with health care institutions.
    • How Aidar Health’s 30-Second Breath Test Is Transforming Patient Monitoring
      MouthLab has the potential to transform patient care. When someone breathes into it for 30 seconds, MouthLab records that person’s respiratory rate and pattern, pulse rate, ECG, SpO2 (oxygen saturation), temperature, heart rate, heart rate variability, blood pressure, and spirometric lung functions, making the data immediately available to caregivers, both professional and personal.
    • Erada receives multimillion-dollar grant
      South Africa-based Erada received the funding from De Beers Group. Erada is developing the world’s first ever saliva-based rapid test for diagnosing and identifying malaria, known as Saliva-based Malaria Asymptomatic and Asexual Rapid Test, to be marketed under the brand SALVA! – with the solution due to be launched globally during World Malaria Day in April 2020.

Other news

Source: ventures.jhu.edu